Griffin Asset Management, Inc. Abb Vie Inc. Transaction History

Griffin Asset Management, Inc.

$879 Million
Q3 2024

A detailed history of Griffin Asset Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 80,582 shares of ABBV stock, worth $14.1 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares

80,582

Previous 83,528 3.53%

Holding current value

$14.1 Million

Previous $14.3 Million 11.08%

% of portfolio

1.81%

Previous 1.68%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$163.84 - $199.33 $482,672 - $587,226	-2,946 Reduced 3.53%	80,582 $15.9 Million
Q2 2024 Jul 23, 2024	BUY	$154.79 - $180.76 $11,454 - $13,376	74 Added 0.09%	83,528 $14.3 Million
Q1 2024 Apr 17, 2024	SELL	$159.82 - $182.1 $942,298 - $1.07 Million	-5,896 Reduced 6.6%	83,454 $15.2 Million
Q4 2023 Jan 19, 2024	SELL	$137.6 - $154.97 $26,556 - $29,909	-193 Reduced 0.22%	89,350 $13.8 Million
Q3 2023 Oct 19, 2023	BUY	$133.59 - $154.65 $2,671 - $3,093	20 Added 0.02%	89,543 $13.3 Million
Q2 2023 Aug 01, 2023	BUY	$132.51 - $164.9 $202,210 - $251,637	1,526 Added 1.73%	89,523 $12.1 Million
Q1 2023 May 09, 2023	SELL	$144.61 - $166.54 $119,014 - $137,062	-823 Reduced 0.93%	87,997 $14 Million
Q4 2022 Jan 20, 2023	BUY	$138.31 - $165.87 $352,828 - $423,134	2,551 Added 2.96%	88,820 $0
Q3 2022 Oct 19, 2022	SELL	$134.21 - $153.93 $57,844 - $66,343	-431 Reduced 0.5%	86,269 $11.6 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $1.05 Million - $1.34 Million	-7,643 Reduced 8.1%	86,700 $13.3 Million
Q1 2022 Apr 12, 2022	SELL	$131.98 - $163.75 $1.86 Million - $2.3 Million	-14,063 Reduced 12.97%	94,343 $15.3 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $533,389 - $674,892	4,965 Added 4.8%	108,406 $14.7 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $11.5 Million - $13 Million	-108,041 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $21,252 - $23,676	202 Added 0.19%	108,041 $12.2 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $211,044 - $232,335	2,063 Added 1.95%	107,839 $11.7 Million
Q4 2020 Jan 27, 2021	BUY	$80.49 - $108.67 $398,103 - $537,481	4,946 Added 4.91%	105,776 $11.3 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $1.79 Million - $2.1 Million	-20,803 Reduced 17.1%	100,830 $8.83 Million
Q2 2020 Aug 18, 2020	BUY	$73.37 - $98.18 $350,341 - $468,809	4,775 Added 4.09%	121,633 $11.9 Million
Q1 2020 May 18, 2020	BUY	$64.5 - $97.79 $2,580 - $3,911	40 Added 0.03%	116,858 $8.9 Million
Q4 2019 Feb 11, 2020	BUY	$72.13 - $90.25 $47,533 - $59,474	659 Added 0.57%	116,818 $10.3 Million
Q3 2019 Nov 05, 2019	BUY	$62.98 - $75.72 $40,874 - $49,142	649 Added 0.56%	116,159 $8.8 Million
Q2 2019 Aug 19, 2019	BUY	$65.7 - $83.98 $129,823 - $165,944	1,976 Added 1.74%	115,510 $8.4 Million
Q1 2019 May 08, 2019	SELL	$77.14 - $90.79 $1.25 Million - $1.47 Million	-16,189 Reduced 12.48%	113,534 $9.15 Million
Q4 2018 Mar 01, 2019	BUY	$77.85 - $96.01 $452,775 - $558,394	5,816 Added 4.69%	129,723 $12 Million
Q3 2018 Nov 19, 2018	BUY	$88.91 - $98.84 $101,624 - $112,974	1,143 Added 0.93%	123,907 $11.7 Million
Q2 2018 Aug 15, 2018	SELL	$89.78 - $106.23 $182,253 - $215,646	-2,030 Reduced 1.63%	122,764 $11.4 Million
Q1 2018 May 16, 2018	SELL	$92.01 - $123.21 $351,846 - $471,155	-3,824 Reduced 2.97%	124,794 $11.8 Million
Q4 2017 Feb 20, 2018	SELL	$89.56 - $98.21 $1.82 Million - $1.99 Million	-20,289 Reduced 13.63%	128,618 $12.4 Million
Q3 2017 Nov 15, 2017	BUY	$69.85 - $89.22 $1.62 Million - $2.06 Million	23,128 Added 18.39%	148,907 $13.2 Million
Q2 2017 Aug 29, 2017	BUY	N/A	125,779	125,779 $9.12 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account

Griffin Asset Management, Inc. Abb Vie Inc. Transaction History